#USA #London #financial results #Clarivate #2025

Clarivate Shares Fourth Quarter and Full Year Financial Results for 2025

On February 24, 2026, Clarivate Plc (NYSE: CLVT) unveiled its financial performance for the fourth quarter and full year 2025, showcasing substantial advancements and insightful strategies as the company fortifies its position as a leader in transformative intelligence.

Executive Insights

In a statement, Matti Shem Tov, CEO of Clarivate, asserted, “In 2025, we achieved remarkable innovation and growth initiatives. Our commitment to the Value Creation Plan enabled us to streamline our business operations, enhance our sales execution, and invest in proprietary capabilities, particularly in Agentic AI across our offerings. Consequently, we experienced nearly 2% organic growth in Annual Contract Value (ACV) while significantly boosting free cash flow.”

He further emphasized the company’s drive towards operational efficiency and customer value, asserting that 2026 promises to bring even greater focus and tactical execution.

Fourth Quarter Overview

For the fourth quarter of 2025, total revenues registered at $617 million, a decline compared to $663 million from the same period in 2024. Despite facing challenges due to inorganic divestitures, organic revenue held steady, decreasing by only 1.2%. Subscription revenues slightly increased by 1.0% to $405.8 million, buoyed by new client acquisitions and improved customer retention strategies. Furthermore, net income exhibited substantial improvement, escalating to $3.1 million from a net loss of $191.8 million year-on-year.

During this quarter, the adjusted EBITDA stood at $254.6 million, overshadowed by the same period in 2024, which reported $285.3 million.

Full Year Insights

Throughout the entirety of 2025, total revenue amounted to $2.455 billion, down from $2.557 billion in 2024. This decline was primarily attributed to strategic divestitures, which narrowed the operational scope of Clarivate's offerings. Organic revenues displayed a modest downturn of 0.1%, countered effectively by a sustained organic growth in recurring revenue by 0.6%. The company committed to refining its service offerings, resulting in a significant uplift in subscription revenue making up 88% of total revenue, a commendable rise from 80% in the prior year.

Net loss for the full year reached $201.1 million, an improvement from $636.7 million in 2024, signaling a transformative year for the organization.

Cash Flow and Shareholder Return

Clarivate proudly reported operating cash flow exceeding $628 million for 2025, alongside an impressive free cash flow of approximately $365 million. The company has initiated comprehensive share repurchase programs, claiming nearly $225 million worth during the same fiscal year, even furthering shareholder value through returns.

Anticipated Future Growth

Looking forward to 2026, Clarivate forecasts positive momentum with an organic ACV growth projected between 2.0% and 3.0%. The expected increase in recurring revenue is anticipated to fall between 0.75% to 2.25%. Revenue estimates for the year range from $2.30 billion to $2.42 billion, accompanied by an expected adjusted EBITDA increase between $980 million and $1.04 billion.

The company also announced its readiness to divest its Life Sciences and Healthcare segment, a decisive move intended to amplify its focus on Academia, Government, and Intellectual Property markets. Morgan Stanley has been appointed as a financial advisor to facilitate this potential sale.

In closing, Clarivate's fourth quarter and annual results affirm a transformative strategy in place, elucidating the company's strategic path as it strides towards fortifying its market position amid the intricacies of evolving industry demands.